The genetic and hearing screening program identified 425 of 32 512 infants (1.31%; 95% CI, 1.19%-1.44%) with SLC26A4 variation who were at risk for EVA-associated HL (Table 3). Here, SLC26A4 is linked to Hodgkins lymphoma.